Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS3233 for Primary Prevention of Type 2 Diabetes Mellitus
NCT01531933Phase 3Completed
- Sponsor
- Dexa Medica
- Start
- Nov 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS3233 in prediabetes, sponsored by Dexa Medica. Started Nov 2011; status: completed.
02
Drugs
DLBS3233
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT01531933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01531933.